Document is current
Any future updates will be listed below
-
Authors
Yoshida, Naoya
Eto, Kojiro
Horinouchi, Tomo
Shiraishi, Shinya
Kanemitsu, Kosuke
Ofuchi, Takashi
Tajiri, Takuya
Adachi, Yuki
Horino, Taichi
Morito, Atsushi
Mitsuura, Chishou
Maeda, Yuto
Hara, Yoshihiro
Matsumoto, Chihiro
Baba, Hideo
- License Information
-
More Information
Article History
Received: 23 January 2023
Accepted: 25 April 2023
First Online: 2 May 2023
Declarations
:
: Dr. Naoya Yoshida belongs to a department supported by Chugai Pharmaceutical Co., Ltd. and Yakuruto Honsya Co., Ltd., but has no conflicts of interest regarding this research.Other co-authors (KE, TH, SS, KK, TO, TT, YA, TH, AM, CM, YM, YH, CM, and HB) have no conflicts of interest or financial ties to disclose.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. The institutional ethics committee approved the study procedures and waived the need for written informed consent from the patients owing to the retrospective nature of the study (registry number 2518).
